Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,634350,Apr4,Acute phase response QTL 4,6,,orosomucoid 1 amount (VT:0010541),plasma orosomucoid 1 level (CMO:0001467),12,4210051,49210051,Rat,n/a,region,qtl 1000,634351,Apr5,Acute phase response QTL 5,6.7,,blood interleukin-6 amount (VT:0008595),plasma interleukin-6 level (CMO:0001927),12,2513442,47513442,Rat,n/a,region,qtl 1000,1598855,Bp294,Blood pressure QTL 294,3.5,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),12,1,36919844,Rat,n/a,region,qtl 1000,6893681,Bw109,Body weight QTL 109,2.3,0.004,body mass (VT:0001259),body weight (CMO:0000012),12,1,23758197,Rat,n/a,region,qtl 1000,7411545,Bw128,Body weight QTL 128,5.2,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),12,150810,45150810,Rat,n/a,region,qtl 1000,7411547,Bw129,Body weight QTL 129,,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),6,9223626,52716770,Rat,n/a,region,qtl 1000,1300174,Bw15,Body weight QTL 15,2.93,,body mass (VT:0001259),body weight loss (CMO:0001399),12,1,11765163,Rat,n/a,region,qtl 1000,8694179,Bw150,Body weight QTL 150,2.9,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),12,150810,45150810,Rat,n/a,region,qtl 1000,1581516,Cm56,Cardiac mass QTL 56,4.2,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),12,1,30749723,Rat,n/a,region,qtl 1000,10755457,Coatc14,Coat color QTL 14,,0.01759,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),12,1,23035872,Rat,n/a,region,qtl 1000,61331,Eau2,Experimental allergic uveoretinitis QTL 2,,0.0005,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),12,10256890,31723732,Rat,n/a,region,qtl 1000,1600391,Edcs2,Endometrial carcinoma susceptibility QTL2,3.5,0.01,uterus morphology trait (VT:0001120),percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759),12,8249608,20590080,Rat,n/a,region,qtl 1000,7411597,Foco10,Food consumption QTL 10,,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411641,Foco19,Food consumption QTL 19,27.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411660,Foco28,Food consumption QTL 28,10.9,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,7411586,Foco5,Food consumption QTL 5,5.4,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,7411588,Foco6,Food consumption QTL 6,,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411595,Foco9,Food consumption QTL 9,4,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,2293086,Iddm30,Insulin dependent diabetes mellitus QTL 30,3.82,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),12,10175889,31975590,Rat,n/a,region,qtl 1000,9590086,Insglur6,Insulin/glucose ratio QTL 6,18.97,0.001,blood insulin amount (VT:0001560),calculated plasma insulin level (CMO:0002170),12,150810,45150810,Rat,n/a,region,qtl 1000,2303575,Insul14,Insulin level QTL 14,4,,blood insulin amount (VT:0001560),blood insulin level (CMO:0000349),12,492578,45492578,Rat,n/a,region,qtl 1000,2312418,Kidm41,Kidney mass QTL 41,3.7,0.0001,kidney mass (VT:0002707),single kidney wet weight as percentage of body weight (CMO:0000623),12,1,22650917,Rat,n/a,region,qtl 1000,7387292,Kidm42,Kidney mass QTL 42,3.03,0.0004,kidney mass (VT:0002707),left kidney wet weight (CMO:0000083),12,1,38334225,Rat,n/a,region,qtl 1000,10059594,Kidm46,Kidney mass QTL 46,3.79,0.025,kidney mass (VT:0002707),both kidneys wet weight as percentage of body weight (CMO:0000140),12,9789834,52716770,Rat,n/a,region,qtl 1000,737979,Pia22,Pristane induced arthritis QTL 22,53.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),12,2475687,47475687,Rat,n/a,region,qtl 1000,2302042,Pia38,Pristane induced arthritis QTL 38,3.5,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),12,2513442,47513442,Rat,n/a,region,qtl 1000,8552964,Pigfal17,Plasma insulin-like growth factor 1 level QTL 17,3.5,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223626,52716770,Rat,n/a,region,qtl 1000,8552912,Pigfal6,Plasma insulin-like growth factor 1 level QTL 6,5,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223630,52716770,Rat,n/a,region,qtl 1000,8552918,Pigfal7,Plasma insulin-like growth factor 1 level QTL 7,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223626,52716770,Rat,n/a,region,qtl 1000,1302792,Scl21,Serum cholesterol level QTL 21,3.8,0.0011,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),12,8954593,27911196,Rat,n/a,region,qtl 1000,9590147,Scort7,Serum corticosterone level QTL 7,13.61,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),12,150810,45150810,Rat,n/a,region,qtl 1000,10450854,Stl34,Serum triglyceride level QTL 34,3.5,0.05,blood LDL triglyceride amount (VT:0010699),blood lipoprotein triglyceride level (CMO:0002685),12,1,22853017,Rat,n/a,region,qtl 1000,724526,Uae3,Urinary albumin excretion QTL 3,4.9,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),12,5406094,12355490,Rat,n/a,region,qtl